According to several studies, the deregulation of glucose metabolism in AD can be controlled by the administration of a hormone known as a potent regulator of glucose homeostasis [11] and of food intake [12], glucagon-like peptide 1 (GLP-1) [13]. The gene discussed is GCG; the disease is Alzheimer disease.